A Multi-center, Randomized, Double-blind, Parallel, Placebo-controlled, Dose-finding, Phase IIa Clinical Trial to Efficacy and Safety of PMK-S005 for the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2018
At a glance
- Drugs PMK-S005 (Primary)
- Indications Peptic ulcer
- Focus Therapeutic Use
- Sponsors PharmaKing
- 20 Jan 2018 Status changed from recruiting to completed.
- 29 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov
- 29 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 May 2016 as reported by ClinicalTrials.gov.